AEON Biopharma, Inc. SEC filings AEON
AEON Biopharma, Inc. has 361 filings in SEC EDGAR's recent list, going back to Dec 23, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Nov 3, 2026 | — |
| 8-K |
Current report
Material agreement
|
Nov 3, 2026 | Nov 2, 2026 |
| DEF 14A | Proxy statement | Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2026 | Oct 23, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Other events
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 15, 2026 | Jul 13, 2026 |
| 424B4 | Prospectus | Jul 15, 2026 | — |
| EFFECT | Filing | Jul 13, 2026 | — |
| S-1MEF | Filing | Jul 13, 2026 | — |
| S-1/A | Amended registration statement | Jul 9, 2026 | — |
| S-1 | Registration statement | Jul 8, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 17, 2026 |
| DRS | Filing | May 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Listing notice
|
Apr 3, 2026 | Mar 31, 2026 |
| S-8 | Employee stock plan registration | Mar 31, 2026 | — |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2026 | Mar 6, 2026 |
| 424B3 | Prospectus | Feb 18, 2026 | — |
| EFFECT | Filing | Feb 17, 2026 | — |
| CORRESP | Letter to the SEC | Feb 12, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2026 | — |
| S-3 | Shelf registration | Feb 9, 2026 | — |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Shareholder vote results, Regulation FD disclosure, Other events
|
Jan 21, 2026 | Jan 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| DEF 14A | Proxy statement | Dec 29, 2025 | Dec 29, 2025 |
| PRE 14A | Preliminary proxy statement | Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 15, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2025 | Dec 4, 2025 |
| DEFA14A | Additional proxy material | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| DEFA14A | Additional proxy material | Nov 13, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 13, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2025 | Sep 8, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 424B5 | Prospectus supplement | Jun 16, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 13, 2025 |
| 10-Q/A | Amended quarterly report | Jun 11, 2025 | Mar 31, 2025 |
| 10-K/A | Amended annual report | Jun 11, 2025 | Dec 31, 2024 |
| DEFR14A | Filing | Jun 11, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2025 | May 20, 2025 |
| S-8 | Employee stock plan registration | May 14, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 29, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 25, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 21, 2025 | Apr 19, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2025 | Apr 3, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 27, 2025 | Mar 24, 2025 |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2025 | Mar 10, 2025 |
| UPLOAD | Letter from the SEC | Feb 28, 2025 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Feb 24, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 7, 2025 | Feb 3, 2025 |
| DEF 14A | Proxy statement | Jan 23, 2025 | Feb 24, 2025 |
| PRE 14A | Preliminary proxy statement | Jan 13, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 7, 2025 | Jan 6, 2025 |
| 424B5 | Prospectus supplement | Jan 7, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2025 | Jan 6, 2025 |
| 424B5 | Prospectus supplement | Jan 6, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 20, 2024 | Dec 18, 2024 |
| 424B3 | Prospectus | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 7, 2024 | Oct 7, 2024 |
| EFFECT | Filing | Aug 21, 2024 | — |
| 424B5 | Prospectus supplement | Aug 21, 2024 | — |
| CORRESP | Letter to the SEC | Aug 20, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2024 | — |
| S-3 | Shelf registration | Aug 15, 2024 | — |
| 424B3 | Prospectus | Aug 12, 2024 | — |
| 10-K/A | Amended annual report | Aug 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| EFFECT | Filing | Aug 5, 2024 | — |
| 424B3 | Prospectus | Aug 5, 2024 | — |
| CORRESP | Letter to the SEC | Aug 2, 2024 | — |
| CORRESP | Letter to the SEC | Jul 23, 2024 | — |
| S-1/A | Amended registration statement | Jul 23, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2024 | — |
| 8-K |
Current report
Other events
|
Jul 9, 2024 | Jul 9, 2024 |
| CORRESP | Letter to the SEC | Jul 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 14, 2024 |
| CORRESP | Letter to the SEC | May 31, 2024 | — |
| S-1/A | Amended registration statement | May 31, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
May 16, 2024 | May 16, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| ARS/A | Filing | May 14, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | May 14, 2024 | — |
| 10-K/A | Amended annual report | May 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Restatement
|
May 3, 2024 | May 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 3, 2024 | May 3, 2024 |
| UPLOAD | Letter from the SEC | Apr 30, 2024 | — |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 14, 2024 |
| 25-NSE | Delisting notice | Apr 29, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Apr 17, 2024 | Apr 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 15, 2024 | Apr 15, 2024 |
| CORRESP | Letter to the SEC | Apr 2, 2024 | — |
| S-1/A | Amended registration statement | Apr 2, 2024 | — |
| S-8 | Employee stock plan registration | Apr 1, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 29, 2024 | Mar 29, 2024 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 10-Q/A | Amended quarterly report | Mar 29, 2024 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 28, 2024 | Mar 24, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure
|
Mar 19, 2024 | Mar 18, 2024 |
| CORRESP | Letter to the SEC | Feb 27, 2024 | — |
| 8-K |
Current report
Restatement
|
Feb 16, 2024 | Feb 14, 2024 |
| UPLOAD | Letter from the SEC | Dec 20, 2023 | — |
| S-1/A | Amended registration statement | Nov 24, 2023 | — |
| CORRESP | Letter to the SEC | Nov 22, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2023 | — |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| S-1/A | Amended registration statement | Oct 23, 2023 | — |
| CORRESP | Letter to the SEC | Oct 20, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 19, 2023 | Oct 19, 2023 |
| 8-K |
Current report
Auditor change
|
Oct 2, 2023 | Sep 28, 2023 |
| UPLOAD | Letter from the SEC | Sep 8, 2023 | — |
| DEL AM | Filing | Aug 22, 2023 | — |
| S-1 | Registration statement | Aug 18, 2023 | — |
| 8-K/A | Amended current report | Aug 14, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jul 27, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 24, 2023 | Jul 24, 2023 |
| CERT | Nyse american certification | Jul 21, 2023 | — |
| 25 | Filing | Jul 21, 2023 | — |
| 8-A12B | Filing | Jul 21, 2023 | — |
| 10-Q | Quarterly report | Jul 21, 2023 | Jun 30, 2023 |
| S-4MEF | Form s-4mef | Jul 18, 2023 | — |
| 425 | Filing | Jul 17, 2023 | — |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jul 17, 2023 | Jul 13, 2023 |
| 425 | Filing | Jul 12, 2023 | — |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jul 12, 2023 | Jul 11, 2023 |
| 425 | Filing | Jul 5, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jul 5, 2023 | Jul 5, 2023 |
| 425 | Filing | Jun 30, 2023 | — |
| DEFA14A | Additional proxy material | Jun 30, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 30, 2023 | Jun 30, 2023 |
| DEFA14A | Additional proxy material | Jun 30, 2023 | — |
| 425 | Filing | Jun 30, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 30, 2023 | Jun 29, 2023 |
| DEFA14A | Additional proxy material | Jun 28, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 28, 2023 | Jun 28, 2023 |
| DEFA14A | Additional proxy material | Jun 26, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 26, 2023 | Jun 26, 2023 |
| DEFA14A | Additional proxy material | Jun 21, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| DEFA14A | Additional proxy material | Jun 15, 2023 | — |
| 8-K |
Current report
Listing notice, Other events
|
Jun 15, 2023 | Jun 15, 2023 |
| DEFA14A | Additional proxy material | Jun 13, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 13, 2023 | Jun 13, 2023 |
| DEFA14A | Additional proxy material | Jun 9, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 9, 2023 | Jun 9, 2023 |
| DEFA14A | Additional proxy material | Jun 6, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 6, 2023 | Jun 6, 2023 |
| 425 | Filing | May 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 17, 2023 | Mar 31, 2023 |
| NT 10-Q | Filing | May 15, 2023 | Mar 31, 2023 |
| EFFECT | Filing | May 12, 2023 | — |
| DEFM14A | Filing | May 12, 2023 | — |
| 424B3 | Prospectus | May 12, 2023 | — |
| CORRESP | Letter to the SEC | May 11, 2023 | — |
| CORRESP | Letter to the SEC | May 9, 2023 | — |
| S-4/A | Filing | May 9, 2023 | — |
| UPLOAD | Letter from the SEC | May 8, 2023 | — |
| 425 | Filing | May 1, 2023 | — |
| 8-K |
Current report
Material agreement
|
May 1, 2023 | Apr 27, 2023 |
| CORRESP | Letter to the SEC | May 1, 2023 | — |
| S-4/A | Form s-4/a | May 1, 2023 | — |
| 10-K/A | Amended annual report | Apr 10, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Apr 5, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Restatement
|
Apr 5, 2023 | Apr 5, 2023 |
| UPLOAD | Letter from the SEC | Mar 23, 2023 | — |
| S-4/A | Form s4 | Mar 10, 2023 | — |
| CORRESP | Letter to the SEC | Mar 9, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2023 | — |
| 425 | Filing | Feb 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2023 | Feb 24, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AEON (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aliso Viejo, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1837607
- Former names
- Priveterra Acquisition Corp. (until Jul 24, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.